Package 68001-522-85

Brand: fulvestrant

Generic: fulvestrant
NDC Package

Package Facts

Identity

Package NDC 68001-522-85
Digits Only 6800152285
Product NDC 68001-522
Product ID 68001-522_e4b34fb8-f651-8d00-e053-2995a90a3d2a
Description

2 SYRINGE, GLASS in 1 CARTON (68001-522-85) / 5 mL in 1 SYRINGE, GLASS (68001-522-86)

Marketing

Marketing Status
Marketed Since 2021-10-29
Brand fulvestrant
Generic fulvestrant
Sample Package No

Linked Drug Pages (1)

FULVESTRANT ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "e4b34fb8-f651-8d00-e053-2995a90a3d2a", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "upc": ["0368001522861"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["477098a1-cd37-48ad-b17f-aef610cb0f57"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (68001-522-85)  / 5 mL in 1 SYRINGE, GLASS (68001-522-86)", "package_ndc": "68001-522-85", "marketing_start_date": "20211029"}], "brand_name": "FULVESTRANT", "product_id": "68001-522_e4b34fb8-f651-8d00-e053-2995a90a3d2a", "dosage_form": "INJECTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "68001-522", "generic_name": "Fulvestrant", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FULVESTRANT", "active_ingredients": [{"name": "FULVESTRANT", "strength": "250 mg/5mL"}], "application_number": "ANDA211689", "marketing_category": "ANDA", "marketing_start_date": "20211029", "listing_expiration_date": "20261231"}